XRCC4 and breast carcinoma: Immunofluorescence assays revealed abnormal expression of CTSL, CTSD, HSPA8, and XRCC4 in CD11b+ cells in tumor tissues than those in paracancerous normal tissues, regardless of breast cancer subtypes (Figure 6G).